Mon - Fri 09:00 - 17:00 +61 3 7016 0801info@aeternahealth.com.au
Preventive Health
Advanced technology
Regenerative medicine technologies
Development and commercialization
Cellular Clinical Research
Innovation for medical practitioners

Immune Cell Application

Adding Life to Life

Immune cell therapy, Cellular immunotherapy, Cancer immunotherapy, Immune-based cancer treatment, Immune cell therapy clinical trials,Immune cell therapy research,Immune cell therapy companies, Immune cell banking,Immune cell preservation, Immune cell storage, Immune cell bank, Immune cell regeneration,Immune cell therapies

1718605429 图片

Aeterna Health’s Immune Cell (iCell) Application is an advanced therapeutic approach aimed at enhancing the immune system’s ability to combat disease. It serves as an adjuvant therapy for cancer and uses cutting-edge cell technology to provide personalized, effective, and safe treatments.

Purpose and Benefits

  • Enhanced Immune Function: iCell therapy boosts the immune system’s ability to detect and eliminate cancer cells and other pathogens.
  • Adjunctive Cancer Treatment: This therapy complements traditional cancer treatments like chemotherapy and radiation, offering an additional layer of defense.
  • Chronic Disease Management: iCell therapy can also assist in managing autoimmune diseases and other conditions related to immune system deficiencies.

Technology and Methodology

  • High Cell Activity: iCells are maintained at optimal activity levels through an automated system with intelligent monitoring.
  • Quality and Safety: All processes meet stringent quality standards, including compliance with Australian TGA regulations, ensuring clinical-grade safety.
  • Advanced Storage: iCells are preserved long-term in a fully automated, -196°C liquid nitrogen system to maintain viability.

Clinical Applications

  • Immune Enhancement: iCell therapy strengthens the body’s overall immune response, aiding in the fight against infections and diseases.
  • Antitumor Capacity: It improves the body’s natural ability to target and destroy cancer cells, making it a valuable addition to conventional cancer treatments.

Research and Development

  • Extensive Clinical Trials: Aeterna Health has gathered significant clinical data over years of trials, supporting the safety and efficacy of iCell therapy.
  • Collaborative Research: Our research, in partnership with institutions like La Trobe University and the Hudson Institute of Medical Research, adheres to the highest scientific standards.

Unique Aspects of iCell Technology

  • CAPRI Cell Integration: iCell technology advances upon CAPRI cells, demonstrating stronger anti-cancer properties and increased immune cell activity.
  • Rapid Manufacturing: iCells are prepared within two weeks following blood sample collection, providing an efficient treatment timeline.
  • Versatility: iCells can be applied to various cancers, infections, and general immune system enhancement.

Please Note: The effectiveness of svCell/iCell therapy can vary based on individual circumstances. We encourage discussions with our medical team to understand how svCell/iCell therapy might align with your needs. Compliance with TGA regulations, Aeterna Health is committed to adhering to the Therapeutic Goods Administration (TGA) regulations. All potential benefits mentioned are based on ongoing research patient safety, and informed decision-making.

Request Information

To learn more about the services offered and the work Aeterna Health is involved with please complete the form below.


Office Address

Suite 1, 990 Toorak Road, Camberwell VIC 3124

Grayclay College of Health
Level 1, 1 Short Street, Southport QLD 4215

+61 3 7016 0801
+61 7 5531 3738
info@aeternahealth.com.au

Clinic Hours

Monday - Friday09:00-17:00